Skip to main content

Table 1 Participants and recruitment

From: Understanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluation

Participants Role Use of EMOS
Interviews
 GP1-INT General Practitioner In general practice and as prescribing lead of Clinical Commissioning Group (CCG) medicines management team
 GP2 General Practitioner In general practice and as respiratory lead at CCG
 GP3 General Practitioner In general practice
 CCGP1 CCG Pharmacist Medication reviews in care homes
 CCGP2 CCG Pharmacist CCG medicines management team
Focus group A - General Practitioners
 GP4 General Practitioner In general practice
 GP1-FG General Practitioner In practice and as prescribing lead of CCG medicines management team
Focus group B – Community Pharmacists
 CP1 Community Pharmacist Aware of, but no access
 CP2 Community Pharmacist Aware of, but no access
 CP3 Community Pharmacist Aware of, but no access
 CP4 Community Pharmacist Aware of, but no access
Focus Group C – Patients
 Pt1 Patient Access through patient passport
 Pt2 Patient Access through patient passport
 Pt3 Patient Access through patient passport
 Pt4 Patient Access through patient passport
Focus Group D - General practice managers
 GPM1 General Practice Manager In general practice
 GPM2 General Practice Manager In general practice
 GPM3 General Practice Manager In general practice
 GPM4 General Practice Manager In general practice
Observation
 CCGP1 CCG Pharmacist Medication reviews in care homes
  1. A number of possible participants were approached but declined to participate. Predominantly this was for reasons of time, workload or lack of use of the system. These included 2 pharmacist technicians, 2 GPs, 2 community pharmacists and 8 general practice managers